通过一种用Lobelia alsinoides制成的局部药膏加速全厚伤口愈合. 乙醇提取物 乙醇提取物
Rex Jeya Rajkumar Samdavid Thanapaul1, Sreeraj K Manikandan1, Mosae Selvakumar Paulraj2
1Division of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore 641114, Tamil Nadu, India.
International journal of molecular sciences
|November 13, 2025
概括
这项研究表明,Lobelia alsinoides (LT) 药膏有效地治愈慢性伤口. 10% LT配方的性能优于SilverexTM,显示出明显的伤口收缩和改善的愈合标记.
科学领域:
- 药理学和植物医学.
- 伤口治愈研究研究 伤口治愈研究
- 自然产品化学 自然产品化学
背景情况:
- 慢性伤口带来了重大的临床挑战,感染和抗菌素耐药性加剧了这一问题.
- 民族医药植物为治疗伤口提供了潜在的治疗替代方案.
- 洛贝利亚阿尔西诺伊德斯Lam. 是一种研究不足的传统用途的草药.
研究的目的:
- 为了评估含有Lobelia alsinoides (LT) 乙醇提取物的局部膏的伤口愈合效果.
- 为了比较LT膏与标准治疗 (SilverexTM) 的疗效.
- 为L. alsinoides在伤口护理中的使用提供科学验证.
主要方法:
- 对LT提取物进行植物化学分析,以检测其化合物,化物和化物.
- 在体外评估抗氧化剂,抗微生物和细胞兼容性特性.
- 使用切割和切割伤口模型在老鼠身上进行体内评估,使用5%和10%的LT膏.
- 伤口组织的生物化学和组织学分析.
- 肝脏和脏毒性的评估.
主要成果:
- LT提取物表现出强大的抗氧化剂,广泛的抗微生物和细胞相容活性.
- 10%的LT膏显著加速了伤口收缩 (99.33%) 并减少了上皮质化时间 (16.1天).
- 观察到增强的抗拉强度 (837.36 g) 和改善的原沉积,ECM重塑和血管生成.
- 没有检测到明显的肝脏或脏毒性.
结论:
- 与SilverexTM相比,Lobelia alsinoides乙醇提取物 (LT) 的伤口愈合效果更好.
- 通过增强原蛋白合成,组织重塑和血管生成,LT促进伤口愈合.
- LT是一种安全,负担得起和可持续的植物治疗剂,用于慢性伤口管理.
相关概念视频
Phases of Wound Repair
7.8K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
7.8K
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K


